Skip to main content
Back to News
Fertility startup Inito raised $29 million in Series B funding, totaling $45 million, to advance at-...
Funding
1 min read
US

Fertility startup Inito raised $29 million in Series B funding, totaling $45 million, to advance at-...

The AMW Read

The article provides an incremental update on Inito's funding and technology application within the AI-driven healthcare/diagnostics vertical.
NoveltySignificance
Healthcare & Bio · Player Map
Inito
Inito

AI in Healthcare

View Company Profile

Fertility startup Inito raised $29 million in Series B funding, totaling $45 million, to advance at-home health diagnostics. They are utilizing AI-designed antibodies to create more sensitive and stable tests, expanding beyond fertility to encompass broader hormone and health monitoring. This innovation positions Inito to redefine diagnostics, offering lab-grade insights from the convenience of home. #AIinHealthcare #MedTech #AtHomeDiagnostics #Biotech #Inito

Explore InitoRead Original

How This Connects

Based on Healthcare & Bio · Player Map

  1. 2d agoIsomorphic Labs explores funding at a valuation of at least $40 billionIsomorphic Labs
  2. 1w agoApheris and Ginkgo launch antibody AI consortium with four pharma companiesApheris
  3. 1w agoEnveda raises $311 million to advance AI-discovered natural-molecule drugsEnveda
  4. 3w agoLevel Five, a game developer, has issued a public apology after facing criticism for what it called...Level Five
  5. 10mo agoFertility startup Inito raised $29 million in Series B funding, totaling $45 million, to advance at-... · THIS ARTICLE

More news from Inito

Stay updated with the latest news and announcements from Inito.

View all Inito news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard